These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 38554191

  • 1. Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway.
    Fu ZY, Huang Y, Lian LS, Huang HT, Zhan SF, Cai Y, Li JX, Liu XH.
    Clin Transl Oncol; 2024 Sep; 26(9):2250-2261. PubMed ID: 38554191
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
    Liu H, Li X, Duan Y, Xie JB, Piao XL.
    J Ethnopharmacol; 2021 May 10; 271():113907. PubMed ID: 33556477
    [Abstract] [Full Text] [Related]

  • 3. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A, Li H, Li R, Lu L, Wu X.
    Oncol Rep; 2018 Oct 10; 40(4):2353-2362. PubMed ID: 30066933
    [Abstract] [Full Text] [Related]

  • 4. [Mechanism of Huachansu Injection against colorectal cancer based on network pharmacology and cellular experimental].
    Meng ZY, Zhao J, Zhu QF, Xiang DF, Meng JJ, Chen JJ, Jiang B, Hu YJ, Xu LY, Zhang XQ, Zou H, Han YL.
    Zhongguo Zhong Yao Za Zhi; 2024 Sep 10; 49(17):4755-4767. PubMed ID: 39307810
    [Abstract] [Full Text] [Related]

  • 5. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods.
    Wang L, Wang Z, Ni Y, Wang X, Zhang T, Hu M, Lian C, Wang X, Zhang J.
    Gene; 2024 Aug 05; 918():148474. PubMed ID: 38670393
    [Abstract] [Full Text] [Related]

  • 6. Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells.
    Zito CR, Jilaveanu LB, Anagnostou V, Rimm D, Bepler G, Maira SM, Hackl W, Camp R, Kluger HM, Chao HH.
    PLoS One; 2012 Aug 05; 7(2):e31331. PubMed ID: 22355357
    [Abstract] [Full Text] [Related]

  • 7. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
    Zhang X, Zeng Y, Qu Q, Zhu J, Liu Z, Ning W, Zeng H, Zhang N, Du W, Chen C, Huang JA.
    Int J Clin Oncol; 2017 Dec 05; 22(6):1026-1033. PubMed ID: 28748356
    [Abstract] [Full Text] [Related]

  • 8. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX, Li Y, Ye N, Liu S, Zou X, Qian J, Wu C, Zhuang Y, Chen M, Zhou JY.
    J Ethnopharmacol; 2024 Jan 30; 319(Pt 3):117342. PubMed ID: 37879505
    [Abstract] [Full Text] [Related]

  • 9. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F, Zhang G, Yang X, Wang M, Wang R, Wan M, Wang J, Wu B, Yan T, Jia Y.
    J Ethnopharmacol; 2023 Mar 01; 303():115933. PubMed ID: 36403742
    [Abstract] [Full Text] [Related]

  • 10. Dual PI3K/mTOR Inhibitor BEZ235 combined with BMS-1166 Promoting Apoptosis in Colorectal Cancer.
    Liu X, Xu W, Li L, Zhang Z, Lu M, Xia X.
    Int J Med Sci; 2024 Mar 01; 21(10):1814-1823. PubMed ID: 39113885
    [Abstract] [Full Text] [Related]

  • 11. Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway.
    Gu F, Zhou Y, Tian L, Chen J, Zhang C, Huang Z, Yu W, Xie K.
    Sci Rep; 2024 Sep 10; 14(1):21130. PubMed ID: 39256509
    [Abstract] [Full Text] [Related]

  • 12. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
    Shukuya T, Yamada T, Koenig MJ, Xu J, Okimoto T, Li F, Amann JM, Carbone DP.
    J Thorac Oncol; 2019 Jun 10; 14(6):1061-1076. PubMed ID: 30825612
    [Abstract] [Full Text] [Related]

  • 13. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
    Chen RJ, Bi QY, Shi JM, Zhong J, Han JT, Ji XM.
    Zhongguo Zhong Yao Za Zhi; 2024 Jan 10; 49(2):471-486. PubMed ID: 38403323
    [Abstract] [Full Text] [Related]

  • 14. Luteoloside induces G0/G1 arrest and pro-death autophagy through the ROS-mediated AKT/mTOR/p70S6K signalling pathway in human non-small cell lung cancer cell lines.
    Zhou M, Shen S, Zhao X, Gong X.
    Biochem Biophys Res Commun; 2017 Dec 09; 494(1-2):263-269. PubMed ID: 29024631
    [Abstract] [Full Text] [Related]

  • 15. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells.
    Songyang Y, Song T, Shi Z, Li W, Yang S, Li D.
    Gene; 2021 Feb 05; 768():145309. PubMed ID: 33197518
    [Abstract] [Full Text] [Related]

  • 16. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M, Zhou LY, Xu N, An Q.
    Thorac Cancer; 2019 Jun 05; 10(6):1319-1333. PubMed ID: 31055884
    [Abstract] [Full Text] [Related]

  • 17. Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway.
    Song L, Liu S, Zhao S.
    Bioengineered; 2022 Apr 05; 13(4):11240-11257. PubMed ID: 35485300
    [Abstract] [Full Text] [Related]

  • 18. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
    Wang N, Feng T, Liu X, Liu Q.
    Acta Pharm; 2020 Sep 01; 70(3):399-409. PubMed ID: 32074070
    [Abstract] [Full Text] [Related]

  • 19. PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway.
    Zhou S, Wang B, Wei Y, Dai P, Chen Y, Xiao Y, Xia H, Chen C, Yin W.
    Cancer Biomark; 2024 Sep 01; 40(1):47-59. PubMed ID: 38306024
    [Abstract] [Full Text] [Related]

  • 20. HYR-2 plays an anti-lung cancer role by regulating PD-L1 and Akkermansia muciniphila.
    Teng L, Wang K, Chen W, Wang YS, Bi L.
    Pharmacol Res; 2020 Oct 01; 160():105086. PubMed ID: 32687951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.